Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Salcher

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Investigation|March 1, 2024
The multivisceral landscape of colorectal cancer metastasis: implications for targeted therapiesDominik Wolf, Stefan Salcher, Andreas Pircher
European Journal of Medicinal Chemistry|December 5, 2024
Circumventing Imatinib resistance in CML: Novel Telmisartan-based cell death modulators with improved activity and stabilityMaximilian Gebhart, Mostafa Alilou, Ronald Gust, et al.
European Journal of Medicinal Chemistry|March 4, 2021
Tackling resistance in chronic myeloid leukemia: Novel cell death modulators with improved efficacyAnna M Schoepf, Stefan Salcher, Petra Obexer, et al.
European Journal of Medicinal Chemistry|October 25, 2019
Overcoming imatinib resistance in chronic myelogenous leukemia cells using non-cytotoxic cell death modulatorsAnna M Schoepf, Stefan Salcher, Petra Obexer, et al.
European Journal of Medicinal Chemistry|April 10, 2020
Identification and development of non-cytotoxic cell death modulators: Impact of sartans and derivatives on PPARγ activation and on growth of imatinib-resistant chronic myelogenous leukemia cellsAnna M Schoepf, Stefan Salcher, Petra Obexer, et al.
Translational Lung Cancer Research|October 19, 2023
Characterization of the tumor microenvironment by single-cell RNA sequencing in non-small cell lung cancer treated with neo-adjuvant immunotherapyLaurenz Nagl, Lena Horvath, Stefan Salcher, et al.
International Journal of Molecular Sciences|August 7, 2021
The Biology of Classic Hairy Cell LeukemiaJan-Paul Bohn, Stefan Salcher, Andreas Pircher, et al.
Chemmedchem|April 17, 2020
Synthesis and Characterization of Telmisartan-Derived Cell Death Modulators to Circumvent Imatinib Resistance in Chronic Myeloid LeukemiaAnna M Schoepf, Stefan Salcher, Verena Hohn, et al.
Journal of Medicinal Chemistry|June 9, 2023
Reaction Behavior of [1,3-Diethyl-4,5-diphenyl-1Paul Kapitza, Amelie Scherfler, Stefan Salcher, et al.
Trends in Cancer|February 15, 2024
Beyond binary: bridging neutrophil diversity to new therapeutic approaches in NSCLCLena Horvath, Constanze Puschmann, Alexandra Scheiber, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Investigation|March 1, 2024
The multivisceral landscape of colorectal cancer metastasis: implications for targeted therapiesDominik Wolf, Stefan Salcher, Andreas Pircher
European Journal of Medicinal Chemistry|December 5, 2024
Circumventing Imatinib resistance in CML: Novel Telmisartan-based cell death modulators with improved activity and stabilityMaximilian Gebhart, Mostafa Alilou, Ronald Gust, et al.
European Journal of Medicinal Chemistry|March 4, 2021
Tackling resistance in chronic myeloid leukemia: Novel cell death modulators with improved efficacyAnna M Schoepf, Stefan Salcher, Petra Obexer, et al.
European Journal of Medicinal Chemistry|October 25, 2019
Overcoming imatinib resistance in chronic myelogenous leukemia cells using non-cytotoxic cell death modulatorsAnna M Schoepf, Stefan Salcher, Petra Obexer, et al.
European Journal of Medicinal Chemistry|April 10, 2020
Identification and development of non-cytotoxic cell death modulators: Impact of sartans and derivatives on PPARγ activation and on growth of imatinib-resistant chronic myelogenous leukemia cellsAnna M Schoepf, Stefan Salcher, Petra Obexer, et al.
Translational Lung Cancer Research|October 19, 2023
Characterization of the tumor microenvironment by single-cell RNA sequencing in non-small cell lung cancer treated with neo-adjuvant immunotherapyLaurenz Nagl, Lena Horvath, Stefan Salcher, et al.
International Journal of Molecular Sciences|August 7, 2021
The Biology of Classic Hairy Cell LeukemiaJan-Paul Bohn, Stefan Salcher, Andreas Pircher, et al.
Chemmedchem|April 17, 2020
Synthesis and Characterization of Telmisartan-Derived Cell Death Modulators to Circumvent Imatinib Resistance in Chronic Myeloid LeukemiaAnna M Schoepf, Stefan Salcher, Verena Hohn, et al.
Journal of Medicinal Chemistry|June 9, 2023
Reaction Behavior of [1,3-Diethyl-4,5-diphenyl-1Paul Kapitza, Amelie Scherfler, Stefan Salcher, et al.
Trends in Cancer|February 15, 2024
Beyond binary: bridging neutrophil diversity to new therapeutic approaches in NSCLCLena Horvath, Constanze Puschmann, Alexandra Scheiber, et al.
Pageof 3